Bulletin
Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Intellia Therapeutics Inc.

NAS: NTLA

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Intellia Therapeutics Inc.

Countdown to close

 --Real time quotes

Jan 25, 2022, 3:33 p.m.

NTLA
/zigman2/quotes/207821052/composite

$

85.75

Change

-2.46 -2.79%

Volume

Volume 953,567

Real time quotes

/zigman2/quotes/207821052/composite

Previous close

$ 88.21

$ 85.75

Change

-2.46 -2.79%

Day low

Day high

$81.33

$90.02

Open

52 week low

52 week high

$43.86

$202.73

Open

Insider Actions for Intellia Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/03/2022 Derek Hicks
EVP, Chief Business Officer 		19,118   Award at $0 per share. 0
11/05/2021 David Lebwohl
EVP, Chief Medical Officer 		200   Disposition at $135.34 per share. 27,068
11/05/2021 David Lebwohl
EVP, Chief Medical Officer 		548   Disposition at $134.07 per share. 73,470
11/05/2021 David Lebwohl
EVP, Chief Medical Officer 		452   Disposition at $132.62 per share. 59,944
11/05/2021 David Lebwohl
EVP, Chief Medical Officer 		1,200   Disposition at $131.71 per share. 158,052
11/05/2021 David Lebwohl
EVP, Chief Medical Officer 		2,400   Derivative/Non-derivative trans. at $12.62 per share. 30,288
10/14/2021 David Lebwohl
EVP, Chief Medical Officer 		250   Disposition at $130.47 per share. 32,617
10/14/2021 David Lebwohl
EVP, Chief Medical Officer 		525   Disposition at $129.83 per share. 68,160
10/14/2021 David Lebwohl
EVP, Chief Medical Officer 		225   Disposition at $129.01 per share. 29,027
10/14/2021 David Lebwohl
EVP, Chief Medical Officer 		849   Disposition at $127.81 per share. 108,510
10/14/2021 David Lebwohl
EVP, Chief Medical Officer 		551   Disposition at $126.92 per share. 69,932
10/14/2021 David Lebwohl
EVP, Chief Medical Officer 		2,400   Derivative/Non-derivative trans. at $12.62 per share. 30,288
10/11/2021 John Francis Crowley
Director 		2,500   Disposition at $119.55 per share. 298,875
10/11/2021 John Francis Crowley
Director 		2,500   Derivative/Non-derivative trans. at $18.83 per share. 47,075
10/05/2021 John Francis Crowley
Director 		200   Disposition at $132.84 per share. 26,568
10/05/2021 John Francis Crowley
Director 		1,846   Disposition at $131.74 per share. 243,192
10/05/2021 John Francis Crowley
Director 		3,759   Disposition at $130.92 per share. 492,128
10/05/2021 John Francis Crowley
Director 		2,915   Disposition at $129.88 per share. 378,600
10/05/2021 John Francis Crowley
Director 		1,280   Disposition at $128.83 per share. 164,902
10/05/2021 John Francis Crowley
Director 		10,000   Derivative/Non-derivative trans. at $18.83 per share. 188,300
09/24/2021 David Lebwohl
EVP, Chief Medical Officer 		7,923   Derivative/Non-derivative trans. at $12.62 per share. 99,988
09/21/2021 David Lebwohl
EVP, Chief Medical Officer 		2,400   Disposition at $149.81 per share. 359,544
09/21/2021 David Lebwohl
EVP, Chief Medical Officer 		2,400   Derivative/Non-derivative trans. at $12.62 per share. 30,288
09/07/2021 Glenn Goddard
EVP, Chief Financial Officer 		3,482   Disposition at $180.12 per share. 627,177
09/07/2021 Glenn Goddard
EVP, Chief Financial Officer 		3,482   Derivative/Non-derivative trans. at $14.58 per share. 50,767
09/01/2021 John M. Leonard
President and CEO; Director 		44,735   Disposition at $170 per share. 7,604,950
09/01/2021 John M. Leonard
President and CEO; Director 		15,985   Derivative/Non-derivative trans. at $18.3 per share. 292,525
09/01/2021 John M. Leonard
President and CEO; Director 		28,750   Derivative/Non-derivative trans. at $23.46 per share. 674,475
08/31/2021 John M. Leonard
President and CEO; Director 		37,833   Disposition at $155 per share. 5,864,115
08/31/2021 Glenn Goddard
EVP, Chief Financial Officer 		24,800   Disposition at $160.22 per share. 3,973,456
08/31/2021 John M. Leonard
President and CEO; Director 		37,833   Derivative/Non-derivative trans. at $14.58 per share. 551,605
08/31/2021 Glenn Goddard
EVP, Chief Financial Officer 		1,817   Derivative/Non-derivative trans. at $14.58 per share. 26,491
08/31/2021 Glenn Goddard
EVP, Chief Financial Officer 		22,983   Derivative/Non-derivative trans. at $19.27 per share. 442,882
Copyright 2022 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
2 Purchases
4 Sales
21,518
2,400
Last 6 months
24 Purchases
68 Sales
399,216
372,175
Last 12 months
52 Purchases
156 Sales
1,161,992
2,368,538

Officers and Executives

Dr. John M. Leonard
President, Chief Executive Officer & Director
Mr. Glenn Goddard
Executive VP, Chief Financial & Accounting Officer
Dr. Laura Sepp-Lorenzino
Chief Scientific Officer & Executive VP
Dr. Eliana Clark
Senior Vice President-Technical Operations
Dr. David Lebwohl
Chief Medical Officer & Executive Vice President
Dr. Christine Foster
SVP-Business Development & Alliance Management
Dr. Walter Strapps
Vice President-Discovery Biology
Mr. Ian Karp
Senior Vice President-Corporate Communications
Ms. Marika St Amand
Chief Human Resources Officer
Mr. James Basta
Secretary, Executive VP & General Counsel
Dr. Frank A. G. M. Verwiel
Chairman
Mr. John Francis Crowley
Independent Director
Dr. Georgia Keresty
Independent Director
Dr. Jean-Francois B. Formela
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Jesse Goodman
Independent Director
Dr. Fred E. Cohen
Independent Director
Link to MarketWatch's Slice.